At-home light and sound therapy for mild Alzheimer’s
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether regular at-home “gamma” light and sound stimulation can help people with mild Alzheimer’s. Participants start with a month at home and are followed to see how they do during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 65 and 100 years old
- Have mild Alzheimer’s, with an MMSE brain-memory test score between 19 and 26
- Be able to agree to the study (or have a legally authorized representative if you cannot)
- Be able to complete the first month of at-home sessions at your main home
- Not be away from your main home for more than about 1 week at a time during the study (your team will check)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether regular “gamma” light and sound stimulation can delay or prevent Alzheimer’s disease-related memory decline in people who are currently not showing dementia but are at higher risk. It uses brain testing (MRI and PET) and memory/language tests over about 13 months.
This study tests whether special lights and sounds (at a specific 'gamma' frequency) can safely affect brain activity. It is an early trial looking at how the brain responds to these gentle sensory stimulations.
This study tests whether a specially designed music intervention can help people with mild Alzheimer's disease. You listen to music with a gamma frequency beat, which may improve brain function and memory.
This study tests whether daily exposure to special lights and sounds at 40 Hz can improve memory and thinking in people with early Alzheimer's disease. It aims to see if this non-invasive approach can help slow down cognitive decline.
This study tests whether a non-invasive 40 Hz light therapy system can help people with early Alzheimer’s. You’ll likely use the device at home and wear a small activity monitor, while doing memory and thinking tests.
This study tests a type of light therapy (called transcranial photobiomodulation) to see if it can help people with early-stage Alzheimer's. It involves coming to Cedars-Sinai for weekly sessions over a period of time.
Hear when a new Alzheimer Disease, Early Onset trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.